International Society on Thrombosis and Haemostasis/LinkedIn
Aug 29, 2026, 17:05
What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
”Could Factor XI inhibition reshape the future of anticoagulation?
Explore the science behind FXI and FXIa inhibitors, an emerging generation of anticoagulant therapies with the potential to influence future clinical practice.
In this recorded session, Jeff Weitz breaks down:
- The major classes of FXI/FXIa inhibitors
- Where they act within the coagulation cascade
- Leading investigational compounds in clinical trials
- Recent clinical data and key study findings
Animated charts and concise summaries make it easy to follow the evolving evidence and understand where the field may be headed next.
Watch the session on demand.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment